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Objective: To evaluate the proportion of “successes” after surgery for femoroacetabular impingement
(FAI) using different external criteria, “feeling better” and “feeling good”, and to determine the corre-
sponding cut-off scores indicating “success” for the Western Ontario and McMaster Universities Oste-
oarthritis Index (WOMAC) (0e10-point response scale), Oxford Hip Score (OHS) and EuroQoL-5D (EQ-5D
and EQ-VAS).
Design: Prospective, observational study based in an orthopaedic hospital. Ninety-nine consecutive
patients with FAI completed the questionnaires before and 6 months after surgery (arthroscopy or mini-
open surgical dislocation). Patient-ratings of change in state (“feeling better”) were assessed using
a global treatment outcome (GTO) item. Acceptability of the current health state was assessed using the
symptom-speciﬁc well-being (SSWB) item. Cut-off (threshold) scores for the different instruments
indicating the minimal clinically important change (MCIC) and acceptable symptom state were calcu-
lated using Receiver Operating Characteristics (ROC) analyses.
Results: Signiﬁcant improvements in all scores (P < 0.001) were recorded 6 months after surgery. The
proportion of good outcomes measured with GTO was 60%; 55% of patients reported having achieved an
acceptable symptom state. The MCIC scores for improvement were 6 for the OHS (0e48 total score
range), 15 for EQ-VAS, 0.16 for EQ-5D index, and 22 for the WOMAC-total score (0e100 total score
range); absolute scores of 40, 80, 0.682 and 8, respectively, were associated with an acceptable
symptom state.
Conclusions: The results show that feeling better does not always equate to feeling good, and that
improvements in outcome scores, even large, do not necessarily indicate acceptability of the current
state. The cut-off values may help in the interpretation of trial results and individual change-scores
recorded in clinical practice.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Femoroacetabular impingement (FAI) occurs when there is
a repetitive impact of the femoral head/neck against the acetabular
labrum and/or its adjacent cartilage. It is a common source of hip
pain and dysfunction in young adults, especially those who are
physically active1,2. In recent years, convincing evidence hasA.F. Mannion, Department of
engghalde 2, 8008 Zurich,
90.
ion).
ork.
s Research Society International. Pemerged to support the hypothesis that FAI is an etiologic factor in
the pathophysiology of osteoarthritis3.
There is a growing body of literature describing the etiology,
diagnosis and treatment of FAI3e5. It is generally agreed that
surgery to preserve the joint should be taken into consideration at
an early stage, since the outcome is usually worse in the presence of
signiﬁcant cartilage damage4. Joint-preserving surgery aims to
create impingement-free motion through restoration of a more
normal morphology in order to alleviate symptoms and to prevent
or delay the progression of irreversible degenerative changes6,7.
The use of patient-oriented measures in the assessment of
treatment outcome has now become a widespread phenomenon8.
A recent systematic review reported mean improvements in pain of
between 25% and 100% after surgery for FAI, with 68e100% ofublished by Elsevier Ltd. All rights reserved.
Table I
Baseline sociodemographic data of the patients (values are mean (SD) unless
otherwise stated)
All patients Female Male
Number (%) 102 (100%) 57 (56%) 45 (44%)
Age (yrs) 35.9 (11.5) 37.7 (12.2) 33.7 (10.3)
BMI (kg m2) 23.5 (4.3) 22.4 (3.0) 25.0 (5.2)
Living condition
Rural 61% 67% 53%
City 39% 33% 47%
Education
Primary school 12% 10% 13%
High school 5% 9% 0%
Professional school 68% 72% 65%
University 15% 9% 22%
Civil status
Married 47% 51% 42%
Single 49% 42% 58%
Divorced/separated 4% 7% 0%
Work activity
Full time 51% 33% 73%
Part time 25% 40% 7%
Student 5% 4% 7%
Homemaker 8% 14% 0%
Retired 1% 0% 2%
Disabled 5% 5% 4%
Other 5% 4% 7%
Operated hip
Right 52% 44% 62%
Left 48% 56% 38%
Contralateral side
Involved but not operated 36% 35% 38%
Involved and operated 8% 5% 11%
Not involved 56% 60% 51%
Comorbidities
None 60% 54% 67%
One 29% 32% 27%
Two 9% 12% 4%
More than three 2% 2% 2%
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improvement in symptoms4. Another review reported that in 10
out of 12 Level IV case series, at least 75% patients declared the
outcome successful9. However, both reviews indicated that the
varying and sometimes non-validated outcome measures used in
the literature provided a challenge in assessing the true value of
treatment, especially on an individual level.
An important and increasingly recognised issue in the ﬁeld of
outcomes research is whether an observed change in an individ-
ual’s scores for symptoms or function is merely caused by
measurement error or constitutes a real change, and whether that
change is also clinically relevant10. In the literature, the latter is
commonly referred to as the “minimal clinically important change”
(MCIC)11. Differences exist in the methods used to quantify the
MCIC, with the most clinically robust of these relying on the
comparison of change scores with an external criterion indicating
the patient’s perception of overall improvement12,13. Other
concepts addressing clinically relevant treatment success include
the symptom-speciﬁc well-being (SSWB) and patient acceptable
symptom state (PASS)14, which indicate the score beyond which
patients consider themselves well or consider their health state to
be acceptable.
An optimal deﬁnition of success may be difﬁcult to ascertain in
the case of FAI, where the indications for surgery can be a mixture
of both symptom relief and joint-preservation, and it is currently
unknown how well these individual markers of success perform in
this pathology. Few studies have quantiﬁed either the responsive-
ness (i.e., the ability to detect change) or the MCIC, PASS, or SSWB
for the instruments used in the assessment of outcome in FAI15.
Determination of such values would assist in interpreting scores/
change scores at the individual level and in establishing realistic
expectations regarding the likely outcome of treatment, to counsel
patients preoperatively.
In the present study, we examined the association between
different expressions of “success” in relation to the early outcome of
surgical treatment for FAI. The concepts under investigation
included both improvement (feeling better) and acceptability of the
current state (feeling good)16. The proportion of successes
measured using these different external criteria was examined, as
were the corresponding cut-off scores associated with a “successful
result” for two commonly used hip outcome instruments (WOMAC
and Oxford-12) and a generic health-related quality of life ques-
tionnaire (EuroQoL-5D).
Methods
Patients, surgery, and study design
One hundred and seventy-two consecutive patients [86 (50%)
men and 86 (50%) women] undergoing either arthroscopic surgery
with labral preservation (surgeon 1) or limited anterolateral open
surgery with labral resection (surgeon 2) for FAI in our hospital
between July 2008 and April 2010 were eligible for participation in
the study. Inclusion criteria included: cam, localized pincer, or
mild-moderate mixed impingement in hips with at most early-OA
(<1, radiographically assessed); arthroscopic or mini-open
osteochondroplasty as the foreseen surgical intervention; and
a good understanding of written German. Exclusion criteria
included: symptomatic hip dysplasia (lateral centre edge angle
<20); combined FAI with a global over-coverage (i.e., coxa pro-
funda or protrusio) and extra-articular impingement; and hips
requiring cartilage repair techniques (for these, the postoperative
restrictions and rehabilitation were more extensive compared with
the included surgical techniques, for which full weight-bearing was
permitted 2 weeks postoperatively).A few weeks before admission for surgery, patients were mailed
an invitation to participate, an information letter, a set of ques-
tionnaires, and an informed consent form. They were requested to
complete the questionnaire booklet and send it back the week
before admission. After 6 months, a second questionnaire booklet
was mailed to those that had returned a preoperative question-
naire, with the request to complete it and return it using the
stamped addressed envelope enclosed. One hundred and twenty-
eight patients (75%) returned the preoperative questionnaire. One
hundred and two (75%) of these also returned a 6-month follow-up
questionnaire. Their sociodemographic characteristics are shown in
Table I. The study was approved by the local ethical committee and
all patients gave their written informed consent to participate.Questionnaires
The preoperative questionnaire booklet contained the following
(1) the Euro Quality of Life-Five Dimensions index (EQ-5D) and the
Euro Quality of Life “visual analogue scale” (EQ-VAS) for health-
related quality of life. The EQ-5D is a standardized instrument
used as a measure of health outcome17,18. It comprises ﬁve
single items e mobility, self-care, usual activities, pain/
discomfort and anxiety/depression e each rated on a 3-point
response scale. Unweighted summary index scores (ranging
from 0.59 to 1) were computed19. The EQ-VAS is a 0e100
scale for assessing current health-related quality of life.
(2) the Oxford Hip Score (OHS). The OHS consists of 12 questions
asking patients to describe their hip pain and function during
Table II
Distribution of responses in relation to the single item questions assessing the
overall outcome of surgery for women, men and for the whole group together
Six-months’ follow-up Women Men P value All
N % N % N %
Change compared with preoperatively
GTO
Helped a lot (0) 17 30% 7 16% 24 24%
Helped (1) 20 36% 16 36% 36 36%
Helped only little (2) 15 27% 16 36% 31 31%
Did not help (3) 3 5% 5 11% 8 8%
Made things worse (4) 1 2% 0 0% 1 1%
Good outcome (0 and 1) 37 66% 23 52% 0.162 60 60%
Poor outcome (2e4) 19 34% 21 48% 40 40%
Total 56 100% 44 100% 100 100%
Acceptability of current state
SSWB
Very satisﬁed (0) 8 14% 5 12% 13 13%
Somewhat satisﬁed (1) 17 30% 11 25% 28 27%
Neither satisﬁed nor
dissatisﬁed (2)
7 12% 8 18% 15 15%
Somewhat dissatisﬁed (3) 11 19% 12 27% 23 23%
Very dissatisﬁed (4) 14 25% 8 18% 22 22%
Acceptable state (0e2) 32 56% 24 55% 0.873 56 55%
Not acceptable state (3e4) 25 44% 20 45% 45 45%
Total 57 100% 44 100% 101 100%
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values from 0 to 4. The responses to the 12 questions are
summed to give a total score ranging from 0 to 48, where 0 is
the worst possible score and 48 is the best score22.
(3) the Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC). This is a 24-item self-administered, disease-
speciﬁc instrument for assessing pain, stiffness and physical
function in osteoarthritis patients23,24. In the present study we
used the version with the 0e10 numeric scale. Five items
address pain, two items address stiffness and 17 items assess
physical function. The scores for each subscale and the total
score were converted to a 0e100 scale with higher scores
indicating a worse health state.
At the 6-month follow-up, the above questionnaires were sup-
plemented with a range of single item questions aimed at assessing
the success of surgery, as follows:
Assessment of change/improvement
(1) global treatment outcome (GTO) adapted fromMannion et al25.
“Howmuch did the operation help your hip problem?” (helped
a lot, helped, helped only little, didn’t help, made things worse)
Assessment of acceptability of current health state
(2) Symptom-speciﬁc well-being (SSWB)26 “If you had to spend
the rest of your life with the symptoms you have now, how
would you feel about it?” (very satisﬁed, somewhat satisﬁed,
neither satisﬁed nor dissatisﬁed, somewhat dissatisﬁed, very
dissatisﬁed)
For some analyses, the 5-point measures of “success” were
collapsed to provide dichotomous (good/poor; acceptable/not
acceptable) outcome variables. As previously published for patients
undergoing elective surgery25, the ﬁrst two categories of the
5-point scale for GTO i.e., “operation helped/helped a lot” were
taken to represent the cut-off for a “good” outcome. For dichoto-
mising the SSWB responses into “acceptable“ vs “not acceptable“
states, we performed receiver operating characteristics (ROC)
analysis of the data from an initial subgroup of patients who had
completed both the 5-point SSWB and the PASS14. The PASS asks
“Taking into account all the activities you have during your daily
life, your level of pain, and also your functional impairment, do you
consider that your current state is satisfactory?” with the answers
“yes” or “no”. These dichotomous responses served as the external
criterion in ROC analysis and the results showed that the top three
categories (very satisﬁed, somewhat satisﬁed, neither/nor) gave the
best indication of an “acceptable state” (90% sensitivity, 90% spec-
iﬁcity; ROC area under the curve (AUC) 0.93, 95% CI 0.85 to 0.98;
unpublished observations).
Statistical analysis
Analyses were performed using the data of the 102 patients who
returned a 6-month follow-up questionnaire. Missing data were
dealt with using the corresponding missing rules for the given
questionnaire.
Descriptive data indicate the proportions (%) of responses in
each global outcome category, and the % categorized as “good” and
“poor” after dichotomisation of the 5-point scales. The signiﬁcance
of the difference in an instrument’s scale/subscale scores at 6
months compared with baseline was analysed using a 2-way
analysis of variance with repeated measures (with gender as the
between-factor and time of assessment the within-factor).
Assumption of sphericity was examined using the Mauchly’s testwith Huynh-Feldt correction where needed. Responsiveness was
given by the standardized response means [SRM¼(posttest mean
pretestmean)/SD changes]27 for the good and poor outcome groups
separately, in order to see whether the questionnaires had the
ability to differentiate between different global outcomes28.
The sensitivity and speciﬁcity of theWOMAC, OHS and EQ-5D in
identifying a “good” outcome, was examined using the ROC
method12. This is considered analogous to evaluating a diagnostic
test, in which the instrument is the diagnostic test and the global
outcome represents the gold standard12. The ROC curve combines
information on sensitivity and speciﬁcity for detecting a good
global outcome and comprises a plot of ‘true-positive rate’ (sensi-
tivity) vs ‘false positive rate’ (1-speciﬁcity) for each of several
possible cut-off points in change score. The ROC AUC indicates the
probability of correctly discriminating between patients with
a “good” and a “poor” result, based on the change in instrument
scores and can range from 0.5 (no accuracy in discriminating) to 1.0
(perfect accuracy in discriminating). The ROC curve was also used
to indicate the cut-off change score for indicating a “good’ outcome
(i.e., the MCIC for improvement; MCICimp) using the 80% speciﬁcity
method), i.e., the cut point showing the best sensitivity for a
response while still achieving at least 80% speciﬁcity, as previously
recommended (in preference to themaximum accuracy method for
improved comparability across different ROC analyses29,30. The
same method was applied to identify the cut-off for the instrument
scores at 6months associated with “satisfactionwith current state”.
Analyses were carried out using SPSS (version 17, SPSS Inc,
Chicago, IL, USA) and Medcalc (MedCalc Statistical Software,
Mariakerke, Belgium). P values <0.05 were considered statistically
signiﬁcant. Unless otherwise stated, all data are presented as the
mean and standard deviation (SD).
Results
Distribution of overall “treatment success” ratings
Table II shows the distribution of responses for the single
items used to assess the “success” of surgery. The proportion of
“good” outcomes, assessed with the GTO item, was slightly but
Table III
Outcome scores before and 6 months after surgery in men and women
N Pre 6 months*
Mean SD Mean SD
EQ-VAS (0 worste100 best)
Gender Men 42 71.4 17.9 78.7 14.5
Women 57 58.7 23.3 73.8 19.0
EQ-5D index (L0.59 worste1.0 best)
Gender Men 44 0.700 0.220 0.805 0.214
Women 57 0.476 0.229 0.707 0.260
OHS (0 worste48 best)
Gender Men 42 36.3 7.1 39.8 6.9
Women 56 29.2 7.7 38.0 7.5
WOMAC pain (0 beste100 worst)
Gender Men 43 31.8 24.3 15.2 16.6
Women 57 46.7 21.0 17.4 17.8
WOMAC stiffness (0 beste100 worst)
Gender Men 43 25.6 27.0 15.5 19.0
Women 57 42.2 28.2 19.5 22.2
WOMAC function (0 beste100 worst)
Gender Men 43 22.9 24.1 12.4 17.2
Women 57 37.0 22.5 14.3 17.4
WOMAC-total score (0 beste100 worst)
Gender Men 43 25.0 23.6 13.2 16.8
Women 57 39.4 21.2 15.5 17.2
* Signiﬁcant effect of time (P<0.001) and gender  time interaction
(0.002 < P < 0.024) for all the outcome measures.
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men (52%).
Fifty-ﬁve percent of patients reported an acceptable symptom
state, with no signiﬁcant gender difference (P ¼ 0.87).
There were no signiﬁcant differences between surgical proce-
dures in the proportions of patients with good and poor outcomes
(arthroscopy, 60% good; mini-open, 61% good), or acceptable and
not acceptable state (arthroscopy, 56% acceptable; mini-open, 55%
acceptable).Changes in outcome scores from preoperatively to 6 months’
follow-up
For all outcome instruments, therewas a signiﬁcant (P< 0.0001)
improvement in scores from before surgery to 6 months after
surgery (Table III). The ceiling effects for WOMAC (12%) and OHSFig. 1. Standardised response means for each outcome instrument, for the good and poor ou(4%) at 6 months were acceptable (<15%). The degree of improve-
ment was not dependent on the type of surgery undertaken
(arthroscopy vs mini-open; P ¼ 0.152e0.823 for all dependent
variables), and hence these data were pooled for further analysis.
The gender time interactions were signiﬁcant (0.002< P< 0.024)
for all the dependent variables. Compared with the men, the
women showed signiﬁcantly (P < 0.001) worse baseline scores but
similar 6-month scores, meaning that the improvements in their
scores for all instruments were signiﬁcantly (P < 0.05) greater than
those for the men (Table III).
Figure 1 shows the effect sizes (SRMs) for each of the
instruments for the “good” and “poor” outcome groups for
the men and women separately. The effect sizes were greater for
the women than for the men for all instruments. The separation
between the effect sizes for the outcome groups (low SRM in the
“poor” group; high SRM in the “good” group) was best (widest)
for the two EQ-5D scales, the OHS and the WOMAC function
subdomain. For the other WOMAC domains, the SRMs in the
poor outcome group were not inconsiderable (especially for the
women) and only slightly lower than those for the good outcome
group.
Outcome scores at 6 months in relation to the acceptability of
symptom status
For each instrument (EQ-5D, OHS, WOMAC and its subdomains)
there was a highly signiﬁcant (P < 0.001) difference between the
mean scores for “acceptable” and “not acceptable” symptom states
at 6 months (Table IV).
The cut-off (threshold) scores indicating an acceptable symptom
state for each questionnaire are shown in Table V. The best esti-
mates revealed that, in order to be considered an “acceptable”
symptom state, scores at 6 months had to be approximately
80e95% of the best achievable score for the given scale.
MCIC scores for EQ-5D, OHS and WOMAC
Table VI shows the cut-off values for the change scores associ-
ated with a good global outcome. These represent the MCIC scores
for improvement (MCICimp), and were equivalent to a change of
20e50% from baseline values, depending on the instrument in
question.tcome groups (based on the dichotomised GTO), shown for men and women separately.
Table IV
Mean scores for each outcome instrument in relation to acceptability of symptom
state as measured by SSWB
Instrument Acceptable Not acceptable Mean difference*
(95% CI)
Mean SD Mean SD
EQ-VAS 84.4 10.4 65.7 18.4 18.7 (12.9e24.4)
EQ-5D index 0.881 0.143 0.587 0.248 0.294 (0.216e0.372)
OHS 42.5 4.6 34.4 7.4 8.1 (6.0e10.6)
WOMAC pain 9.6 11.4 26.1 20.3 16.5 (10.1e22.8)
WOMAC stiffness 9.5 13.3 29.3 24.6 19.9 (12.2e27.5)
WOMAC function 6.4 9.0 22.9 20.9 16.5 (10.3e22.6)
WOMAC-total score 7.4 9.2 24.2 20.4 16.7 (10.7e22.8)
* All mean differences P < 0.001.
Table VI
Results of ROC analysis to determine cut-off change scores for each instrument
indicating a “good global outcome” according to GTO (i.e., the Minimum Clinically
Important Change (MCIC))
Instrument AUC* 95% CI Absolute change scores
cut-off value for
a good outcome (MCIC)
EQ-VAS 0.752 0.654e0.833 15
EQ-5D index 0.780 0.686e0.857 0.16
OHS 0.762 0.665e0.843 6
WOMAC pain 0.735 0.636e0.818 28
WOMAC stiffness 0.626 0.523e0.721 25
WOMAC function 0.705 0.605e0.793 21
WOMAC-total score 0.721 0.622e0.807 22
* All AUCs, P < 0.001.
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Summary of main ﬁndings
The present study examined the association between different
expressions of “success” in relation to the early outcome of surgical
treatment for FAI, quantifying both improvement (“feeling better”),
measured on a transition scale and by the change in outcome
scores, and acceptability of the current state (“feeling good”),
measured on a Likert scale and by the absolute outcome scores at
follow-up, as distinct clinically meaningful measures16. Although
there was a signiﬁcant improvement in scores measured with both
the hip outcome tools and the generic instruments e to an extent
similar to that previously reported at 2 years’ follow-up in studies
using one of the same instruments (WOMAC)4,9,31,32 d only 60%
patients reported notable clinical improvement and 55% deemed
their current symptom state to be acceptable. It was no surprise
that slightly fewer successes were recorded using the latter
approach; previous studies have documented that feeling better
does not always equate to feeling well16. This highlights the fact
that improvements in outcome scores, even large and statistically
signiﬁcant, do not necessarily indicate an acceptable state. Our
study also sought to provide guidance in the interpretation of
individual questionnaire scores and we established that the
threshold values for an acceptable symptom state were equivalent
to 80e95% of the best achievable instrument score and that the
change scores representing the minimal clinically important
improvement for the hip outcome instruments were 6 for OHS
and 21e28 for the various WOMAC domains (equivalent to
improvements of 20e50% on the mean preoperative scores).Table V
Results of ROC analysis to determine cut-off scores for each instrument indicating an
acceptable state according to SSWB
Instrument AUC* 95% CI Cut-off value
EQ-VAS
(0e100)
0.821 0.732e0.890 80
EQ-5D Index
(0.59e1.00)
0.840 0.754e0.905 0.682
OHS
(0e48)
0.825 0.735e0.894 40
WOMAC pain
(0e100)
0.793 0.701e0.867 8
WOMAC stiffness
(0e100)
0.771 0.677e0.849 5
WOMAC function
(0e100)
0.805 0.714e0.877 6
WOMAC-total score
(0e100)
0.808 0.717e0.879 8
* All AUCs, P < 0.001.The external criteria of success
Patient-rated outcomes have been promoted heavily in recent
years, but interpretation of the scores requires knowledge of what
constitutes a meaningful (to the patient) score or change score after
treatment. The provision of cut-off values improves the under-
standability and hence appeal of these outcome measures33. There
is no gold standard methodology for estimating the score that
constitutes the minimal clinically important improvement or the
acceptable symptom state for an instrument. Determination of the
MCICimp, involves either distribution-based methods relying only
on the statistical characteristics (distribution) of the scores or
anchor-based methods, which examine the relationship between
change scores on the target instrument (e.g., WOMAC) and some
independent measure of “worthwhile or important change”34. The
latter follows more intuitively meaningful principles and are the
recommended method of choice35. They require a valid, dichoto-
mous external criterion to indicate “improvement” and this is
commonly given by the patient’s rating of the “global outcome of
treatment”36,37. In the present study, the 5-category Likert scale
was collapsed to produce a dichotomous outcome variable “good”
and “poor”. Although we do not suggest that this measure consti-
tutes a deﬁnitive gold standard for assessing improvement, it is
expected to reﬂect the most important changes to the individual
patient elicited by the operation.Acceptable symptom states after surgery for FAI
The calculation of thresholds associated with an “acceptable
symptom state“ yielded values of 80e95% of the best achievable
score, depending on the scale in question. Few studies have
previously investigated this concept, and none in patients with FAI,
but these % values seem higher than those reported for some other
musculoskeletal disorders. For patients with arthritis-related
disorders, an expert panel in rheumatology proposed PASS values
of 40/100 for the outcomes pain and function, i.e., patients were
considered to be in an acceptable state if their score was below 40
on a 0e100 scale38. For patients with hip OA, a previous study
reported PASS values of 35/100 mm for pain and 34/100 points for
WOMAC function14, which are even higher than the starting point
for many of the FAI patients in the present study (especially the
men). In contrast, the study of Falgarone et al. reported that three-
quarters of all patients suffering from various musculoskeletal
disorders considered their status as “acceptable” only when their
pain level was less than 25/10039 and Wells et al. suggested
a comparable value of <20/10035. These values are closer to the
levels reported in the present study but still indicate a slightly
lesser “tolerance of symptoms” in our FAI patients. For more acute
conditions e of which FAI may be more typical e the intensity of
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chronic disabling conditions, for which greater symptom levels and
impairment appear to be tolerated16,40. Perhaps the relative youth
and active lifestyle of FAI patients also renders them less tolerant of
painful musculoskeletal conditions. Longer-term follow-up of the
patients in the present study will allow us to examine whether the
reported threshold values corresponding to an “acceptable state”
are associatedwith a lesser need for further care or re-intervention;
this should provide further validation of their clinical relevance.
MCIC scores for improvement after surgery for FAI
In the present study we demonstrated, as others have done
(reviewed in van der Roer et al. and Lodhia et al.9,15), that mean
post-treatment scores showed a signiﬁcant improvement on pre-
treatment values, some with relatively high effect sizes. The
change-scores and effect sizes (SRM) were always higher in the
“good” outcome group (see Fig. 1) but for some instruments/sub-
domains (most notably WOMAC pain and stiffness) they were
also moderately high in the “poor” outcome group, indicating that
a number of patients who were not improved according to the
global outcome criterion still showed improvement in these scores.
Ideally, an outcome instrument should not indicate improvement
when none has been deemed to occur, and this suggests a certain
lack of speciﬁcity in the instrument. In order to better quantify the
performance of the different outcome instruments in this respect,
the ROC method was used. The ROC area under the curve (AUC)
indicates the ability of the instrument change scores to distinguish
between improved and not improved statuses, and in the present
study AUCs ranged from 0.63 (WOMAC stiffness) to 0.78 (EQ-5D).
The ROCmethod allowed us to establish that, for a given individual,
a successful outcome would be indicated by a change in WOMAC-
total score of at least 22 points, or by an increase in OHS equal to
or greater than six points. As highlighted by others41,42, it must be
borne in mind that these MCICimp values should not be considered
as absolutely ﬁxed values, but as approximations. The MCICimp can
vary depending on the patient group, their initial scores and the
treatment under investigation, and also depending on the method
and external criterion used for its determination41,42. The values
reported in the current study are applicable to patients assessed 6
months after surgery for FAI and cannot necessarily be extended to
patients with other conditions of the hip such as those undergoing
total hip replacement.
The MCICimp values reported here should be of assistance in the
planning of clinical trials. For example, they can be used to deter-
mine the sample size required to detect a given difference in the
percentage of patients achieving a MCICimp. Being able to express
the results not only as mean values, but also as the proportion of
patients meeting a given threshold for change, or achieving
a certain score postoperatively, should better satisfy the demand
for improved and simpliﬁed reporting of clinical trial results33; this,
in turn, can be expected to facilitate interpretation and hence
implementation of the ﬁndings of such trials in everyday clinical
practice.
Limitations of the study
A number of limitations of the present study require mention.
The follow-up was only 6 months, which might be considered by
some to be rather short. However, since the study was intended to
compare the degrees of success at a given time as judged by
different outcomemeasures rather than report the ﬁnal outcome of
the surgical procedure per se, this period of follow-up was
considered unproblematic. It allowed the early outcome of surgery
to be assessed, once recovery and rehabilitation from the surgeryitself were complete, at which point the main success (or other-
wise) of the speciﬁc intervention should be evident. This is sup-
ported by the ﬁnding of similar scores for the WOMAC in the
present study at 6 months (mean score of 86 when converted on
a 0e100 scalewith 100 indicating a good condition) and in previous
studies with longer follow-ups of 2.0e2.5 years postoperatively
(scores of 87 to 8931,32). Moreover, determination of the cut-off
scores for relevant change/acceptable status are dependent on an
accurate transition rating; intuitively, this is likely to be more
reliable with a shorter recall period43. The uncertainty represented
by the conﬁdence intervals around the various cut-off values
should be taken into considerationwhen interpreting the results of
this study. Indeed, although the AUCs were signiﬁcant, the lower
bounds of their conﬁdence intervals were, for some instruments
and domains, below the 0.70 usually considered acceptable for
accurately differentiating groups.
In presenting the MCICimp values, we made no attempt to split
up the patient population in relation to the type of surgical inter-
vention, gender, severity of baseline status, etc., due to the rela-
tively small size of the study group. These important subgroup
analyses should be performed in future, once the systematic
assessment of outcome in FAI patients has expanded sufﬁciently to
become commonplace in clinical practice.Conclusions
This study attempts to clarify what constitutes a good early
outcome after surgery for FAI, from the perspective of the patient,
in terms of the absolute values and improvements achieved on
various outcome instruments. It shows that feeling better does not
always equate to feeling well, and that improvements in outcome
scores, even large, do not necessarily indicate acceptability of the
current state. The MCICimp values derived for the outcome instru-
ments examined (EQ-5D index, EQ-VAS, OHS,WOMAC) should help
in the interpretation of scores and score changes at the individual
patient level in clinical trials and in daily clinical practice.Author contributions
FMI, AFM, FDN, OH and ML were all responsible for the
conception and design of the main study, of which this sub-study is
part, and FMI, AFM, FDN and ML acquired funding for the project.
OH and ML provided study patients. FMI coordinated all the prac-
tical work and acquisition of data. FMI and AFM performed the
statistical analysis and interpreted the data. AFM created the ﬁrst
draft of the manuscript and FMI, FDN, OH and ML edited and
revised it for important intellectual content. All authors read and
approved the ﬁnal manuscript.
FMI and AFM take responsibility for the integrity of the work as
a whole, from inception to ﬁnished article.Funding
The study was funded by the Schulthess Klinik Research Fund
(internal funding) and by the SYNOS Foundation. None of the
sponsors had any involvement in the study design, in the collection,
analysis and interpretation of data; in the writing of the manu-
script; or in the decision to submit the manuscript for publication.Conﬂict of interests
All the authors declare that they have no ﬁnancial and personal
relationships with other people or organisations that could
potentially and inappropriately inﬂuence (bias) their work and
conclusions.
F.M. Impellizzeri et al. / Osteoarthritis and Cartilage 20 (2012) 638e645644Acknowledgements
The authors would like to thank Sandra Spiss-Schatt, Mirjam
Stoop and Murielle Jeker for their valuable assistance with the data
collection. The study was funded by the Synos Foundation and the
Schulthess Klinik Research Funds.References
1. Leunig M, Ganz R. [FAI e concept and etiology]. Orthopade
2009;38:394e401.
2. Wenger DR, Kishan S, Pring ME. Impingement and childhood
hip disease. J Pediatr Orthop B 2006;15:233e43.
3. Clohisy JC, St John LC, Schutz AL. Surgical treatment of femo-
roacetabular impingement: a systematic review of the litera-
ture. Clin Orthop Relat Res 2010;468:555e64.
4. Ng VY, Arora N, Best TM, Pan X, Ellis TJ. Efﬁcacy of surgery for
femoroacetabular impingement: a systematic review. Am J
Sports Med 2010;38:2337e45.
5. Bedi A, Chen N, Robertson W, Kelly BT. The management of
labral tears and femoroacetabular impingement of the hip in
the young, active patient. Arthroscopy 2008;24:1135e45.
6. Lavigne M, Parvizi J, Beck M, Siebenrock KA, Ganz R, Leunig M.
Anterior femoroacetabular impingement: part I. Techniques of
joint preserving surgery. Clin Orthop Relat Res 2004:61e6.
7. Graves ML, Mast JW. Femoroacetabular impingement: do
outcomes reliably improve with surgical dislocations? Clin
Orthop Relat Res 2009;467:717e23.
8. Poolman RW, Swiontkowski MF, Fairbank JC, Schemitsch EH,
Sprague S, de Vet HC. Outcome instruments: rationale for their
use. J Bone Joint Surg Am 2009;91(Suppl 3):41e9.
9. Stevens MS, Legay DA, Glazebrook MA, Amirault D. The
evidence for hip arthroscopy: grading the current indications.
Arthroscopy 2010;26:1370e83.
10. van der Roer N, Ostelo RW, Bekkering GE, van Tulder MW, de
Vet HC. Minimal clinically important change for pain intensity,
functional status, and general health status in patients with
nonspeciﬁc low back pain. Spine 2006;31:578e82.
11. Stratford PW, Binkley JM, Riddle DL, Guyatt GH. Sensitivity to
change of the Roland-Morris back pain questionnaire: part 1.
Phys Ther 1998;78:1186e96.
12. Deyo RA, Centor RM. Assessing the responsiveness of func-
tional scales to clinical change: an analogy to diagnostic test
performance. Journal of Chronic Diseases 1986;39:897e906.
13. Wells G, Beaton D, Shea B, Boers M, Simon L, Strand V, et al.
Minimal clinically important differences: review of methods.
J Rheumatol 2001;28:406e12.
14. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N,
et al. Evaluation of clinically relevant states in patient reported
outcomes in knee and hip osteoarthritis: the patient accept-
able symptom state. Ann Rheum Dis 2005;64:34e7.
15. Lodhia P, Slobogean GP, Noonan VK, Gilbart MK. Patient-
reported outcome instruments for femoroacetabular impinge-
ment and hip labral pathology: a systematic review of the
clinimetric evidence. Arthroscopy 2010;27:279e86.
16. Tubach F, Dougados M, Falissard B, Baron G, Logeart I,
Ravaud P. Feeling good rather than feeling better matters more
to patients. Arthritis Rheum 2006;55:526e30.
17. Brooks R. EuroQol: the current state of play. Health Policy
1996;37:53e72.
18. Greiner W, Graf v.d. Schulenburg J-M, Piercy J, Eds. (EuroQol)
Plenary Meeting. Discussion Papers. Hannover Uni-Verlag:
WItte 1999.19. Prieto L, Sacristan JA. What is the value of social values? The
uselessness of assessing health-related quality of life through
preference measures. BMC Med Res Methodol 2004;4:10.
20. Dawson J, Fitzpatrick R, Carr A, Murray D. Questionnaire on the
perceptions of patients about total hip replacement. J Bone
Joint Surg Br 1996;78:185e90.
21. Naal FD, Sieverding M, Impellizzeri FM, von Knoch F,
Mannion AF, Leunig M. Reliability and validity of the cross-
culturally adapted German Oxford hip score. Clin Orthop
Relat Res 2009;467:952e7.
22. Murray DW, Fitzpatrick R, Rogers K, Pandit H, Beard DJ, Carr AJ,
et al. The use of the Oxford hip and knee scores. J Bone Joint
Surg Br 2007;89:1010e4.
23. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW.
Validation study of WOMAC: a health status instrument for
measuring clinically important patient relevant outcomes to
antirheumatic drug therapy in patients with osteoarthritis of
the hip or knee. J Rheumatol 1988;15:1833e40.
24. Stucki G, Meier D, Stucki S, Michel BA, Tyndall AG, Dick W,
et al. [Evaluation of a German version of WOMAC (Western
Ontario and McMaster Universities) Arthrosis Index].
Z Rheumatol 1996;55:40e9.
25. Mannion AF, Porchet F, Kleinstuck FS, Lattig F, Jeszenszky D,
Bartanusz V, et al. The quality of spine surgery from the
patient’s perspective: part 2. Minimal clinically important
difference for improvement and deterioration as measured
with the Core Outcome Measures Index. Eur Spine J
2009;18:374e9.
26. Cherkin DC, Deyo RA, Street JH, Barlow W. Predicting poor
outcomes for back pain seen in primary care using patients’
own criteria. Spine (Phila Pa 1976) 1996;21:2900e7.
27. Stratford PW, Spadoni G, Kennedy D, Westaway MD,
Alcock GK. Seven points to consider when investigating
a measure’s ability to detect change. Physiother Can
2002;54:16e24.
28. Beaton DE, Bombardier C, Katz JN, Wright JG. A taxonomy for
responsiveness. J Clin Epidemiol 2001;54:1204e17.
29. Aletaha D, Funovits J, Ward MM, Smolen JS, Kvien TK.
Perception of improvement in patients with rheumatoid
arthritis varies with disease activity levels at baseline. Arthritis
Rheum 2009;61:313e20.
30. Aletaha D, Smolen J, Ward MM. Measuring function in rheu-
matoid arthritis: identifying reversible and irreversible
components. Arthritis Rheum 2006;54:2784e92.
31. Ilizaliturri Jr VM, Nossa-Barrera JM, Acosta-Rodriguez E,
Camacho-Galindo J. Arthroscopic treatment of femo-
roacetabular impingement secondary to paediatric hip disor-
ders. J Bone Joint Surg Br 2007;89:1025e30.
32. Ilizaliturri Jr VM, Orozco-Rodriguez L, Acosta-Rodriguez E,
Camacho-Galindo J. Arthroscopic treatment of cam-type fem-
oroacetabular impingement: preliminary report at 2 years
minimum follow-up. J Arthroplasty 2008;23:226e34.
33. Schunemann HJ, Akl EA, Guyatt GH. Interpreting the results
of patient reported outcome measures in clinical trials: the
clinician’s perspective. Health Qual Life Outcomes 2006;
4:62.
34. Brozek JL, Guyatt GH, Schunemann HJ. How a well-grounded
minimal important difference can enhance transparency of
labelling claims and improve interpretation of a patient
reported outcome measure. Health Qual Life Outcomes
2006;4:69.
35. Wells G, Anderson J, Beaton D, Bellamy N, Boers M,
Bombardier C, et al. Minimal clinically important difference
module: summary, recommendations, and research agenda.
J Rheumatol 2001;28:452e4.
F.M. Impellizzeri et al. / Osteoarthritis and Cartilage 20 (2012) 638e645 64536. Beurskens AJHM, de Vet HCW, Köke AJA. Responsiveness of
functional status in low back pain: a comparison of different
instruments. Pain 1996;65:71e6.
37. Crosby RD, Kolotkin RL, Williams GR. Deﬁning clinically
meaningful change in health-related quality of life. J Clin
Epidemiol 2003;56:395e407.
38. Tubach F, Ravaud P, Beaton D, Boers M, Bombardier C,
Felson DT, et al. Minimal clinically important improvement
and patient acceptable symptom state for subjective outcome
measures in rheumatic disorders. J Rheumatol 2007;34:
1188e93.
39. Falgarone G, Zerkak D, Bauer C, Messow M, Dougados M.
How to deﬁne a Minimal clinically individual state (MCIS)
with pain VAS in daily practice for patients suffering frommusculoskeletal disorders. Clin Exp Rheumatol 2005;23:
235e8.
40. Pham T, Tubach F. Patient acceptable symptomatic state
(PASS). Joint Bone Spine 2009;76:321e3.
41. Ostelo RW, Deyo RA, Stratford P, Waddell G, Croft P, Von
Korff M, et al. Interpreting change scores for pain and func-
tional status in low back pain: towards international consensus
regarding minimal important change. Spine 2008;33:90e4.
42. Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR,
Aaronson NK. Responsiveness and minimal important differ-
ences for patient reported outcomes. Health Qual Life
Outcomes 2006;4:70.
43. Guyatt GH, Norman GR, Juniper EF, Grifﬁth LE. A critical look at
transition ratings. J Clin Epidemiol 2002;55:900e8.
